4//SEC Filing
Kumar Ravindra 4
Accession 0001179110-19-004913
CIK 0001280600other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:58 PM ET
Size
7.9 KB
Accession
0001179110-19-004913
Insider Transaction Report
Form 4
Kumar Ravindra
VP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2019-04-09$45.46/sh−100$4,546→ 90,445 total - Sale
Common Stock
2019-04-09$44.24/sh−70$3,097→ 90,375 total - Sale
Common Stock
2019-04-09$44.62/sh−3,452$154,028→ 90,545 total
Footnotes (2)
- [F1]The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.34 to $45.09 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Documents
Issuer
ACCELERON PHARMA INC
CIK 0001280600
Entity typeother
Related Parties
1- filerCIK 0001586835
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:58 PM ET
- Size
- 7.9 KB